drugset / Trial / NCT04343287
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Timeline
- Start
- 2020-01-15
- Primary completion
- 2020-06-23
- Completion
- 2020-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BRM421 | Unknown | — | — |